Germline and tumor BRCA1/2 pathogenic variants in Chinese triple-negative breast carcinomas
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-021-03696-2
Abstract: BRCA1/2 screening for all triple-negative breast cancer (TNBC) patients younger than 60 years may still be an economic burden in China. Further evidences that include incidence and outcome of BRCA1/2 pathogenic variants (PV) screened based… read more here.
Keywords: germline tumor; brca1; tumor brca1; triple negative ... See more keywords